FDA Shuts Down Three Nungua Facilities Over Sale of Laughing Gas and Codeine-Laced Products

The Food and Drugs Authority (FDA) of Ghana, in a joint operation with the Criminal Investigations Department (CID) of the Ghana Police Service, has closed three prominent facilities in Nungua for the distribution and sale of illicit and unregistered products. The enforcement action targeted establishments found to be peddling harmful substances, including nitrous oxide—commonly known as "laughing gas"—codeine-laced cough syrups, and unregistered shisha products. This crackdown follows months of undercover investigations aimed at curbing the rising misuse of controlled substances and protecting the well-being of the public in the Greater Accra Region.

Among the businesses affected by the closure are well-known entertainment hubs, including Italian Boy Lounge and Liquid Zero Pub. According to the FDA, these facilities were flagrantly violating public health regulations by offering regulated medicines and hazardous substances for recreational use. Specifically, the sale of nitrous oxide for inhalation and the mixing of the antihistamine Benylin with codeine were highlighted as grave public health concerns. These practices not only violate the Public Health Act but also pose significant risks of addiction, respiratory distress, and long-term health complications for unsuspecting patrons.

The operation is part of a broader regulatory strategy to sanitize the market and ensure that all products consumed by the Ghanaian public meet stringent safety and efficacy standards. The FDA noted that the unregistered shisha products found on-site lacked the necessary health warnings and ingredient disclosures required by law, further endangering consumers. By collaborating with the CID, the authority demonstrated its resolve to use criminal enforcement mechanisms where administrative warnings have failed. The months-long surveillance preceding this action indicates a more proactive and intelligence-led approach by the regulator in monitoring the Nungua enclave.

Moving forward, the FDA has reiterated its commitment to continuous monitoring and enforcement across the country to protect public health and safety. The authority has urged the general public to remain vigilant and report any suspicious activities or the sale of prohibited substances in their communities. As investigations into the owners of the shuttered facilities continue, the FDA has issued a stern warning to other businesses that they will face similar sanctions and prosecution if found to be in breach of the law, emphasizing that the health of Ghanaians remains a non-negotiable priority.